on US orders over $100
on all US orders over $100
Covidien Pharmaceuticals adds to an already expansive line of products for wound care, diagnostics, and surgical procedures, among many others. It is believed that by forming a separate entity, their objectives, strategies, and execution can be better performed than if considered in conjunction with the other business units. Because most of the focus and return (around 80%) is currently centered around medical supplies, this will offer the pharmaceutical line its own budget and flexibility to pursue new, innovative product development without detracting from the main medical strategy.
The establishment of Covidien Pharmaceuticals is expected to overcome significant constraints and liabilities that have affected the growth of both their medical and drug manufacturers. Board members believe that this will be a positive move forward for the company and are offering additional information for shareholders by way of teleconference through December 22 of this year. For more information on Covidien Pharmaceuticals visit investor.covidien.com.
To order Covidien products, click here, or call 1-888-687-4334 to speak with one of our trained representatives for more information today!